# Integrated network analysis and experimental validation identify CCNA2, CD44, and STAT1 as clinically relevant hub genes in oral squamous cell carcinoma

**Authors:** Mingyang Bu, Yue Gu, Yuhan Meng, Yunyi Cui, Qianli Wu, Yali Kong, Haoyang Liu, Yi Chen, Jiajun Zhang, Lizhen Guo, Yakun Yang, Dongyang Huang, Zhe Ma

PMC · DOI: 10.3389/fmolb.2026.1748821 · Frontiers in Molecular Biosciences · 2026-02-09

## TL;DR

This study identifies CCNA2, CD44, and STAT1 as key genes in oral cancer, offering new diagnostic and treatment insights through network analysis and experiments.

## Contribution

The study identifies CCNA2, CD44, and STAT1 as reproducible hub genes in oral squamous cell carcinoma with clinical relevance.

## Key findings

- CCNA2, CD44, and STAT1 are consistently upregulated across multiple cohorts and show prognostic and diagnostic significance.
- The genes are embedded in pathways related to proliferation, adhesion, and stress response.
- Experimental validation confirms elevated expression of these genes in OSCC tissues and cell lines.

## Abstract

Oral squamous cell carcinoma remains a major clinical challenge, with only marginal gains in long-term survival due to frequent recurrence, lymphatic dissemination and therapeutic resistance. Robust and biologically grounded molecular determinants are needed to improve tumor characterization and facilitate translational advances. Transcriptomic profiles from GSE30784, GSE9844 and TCGA-HNSC were integrated to identify reproducible dysregulated genes, followed by construction of a high-confidence PPI network for hub gene prioritization. Prognostic and diagnostic relevance was assessed using Kaplan–Meier, Cox regression and ROC analyses. Experimental validation was performed by immunohistochemistry in human OSCC tissues and by qPCR in OSCC cell lines. Cross-cohort integration yielded a reproducible set of DEGs, from which CCNA2, CD44 and STAT1 emerged as network-defined hub genes. All three genes were consistently upregulated across independent cohorts and showed significant prognostic and diagnostic associations. Functional enrichment indicated that these genes are embedded in proliferation-, adhesion- and stress-response–related signaling programs. Experimental assays further confirmed their elevated expression at both transcript and protein levels in OSCC tissues and cell models. CCNA2, CD44 and STAT1 constitute reproducible and functionally anchored hub genes in OSCC, carrying both diagnostic and prognostic implications. These findings substantially refine the molecular understanding of OSCC and provide rational entry points for subsequent mechanistic and translational investigations.

## Linked entities

- **Genes:** CCNA2 (cyclin A2) [NCBI Gene 890], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772]
- **Diseases:** oral squamous cell carcinoma (MONDO:0004958)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CRNN (cornulin) [NCBI Gene 49860] {aka C1orf10, PDRC1, SEP53}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PVR (PVR cell adhesion molecule) [NCBI Gene 5817] {aka CD155, HVED, NECL5, Necl-5, PVS, TAGE4}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}
- **Diseases:** squamous tumors (MESH:D018307), lymph node metastasis (MESH:D008207), Cancer (MESH:D009369), head and neck malignancies (MESH:D006258), epithelial malignancies (MESH:D002277), HL (MESH:C538324), Head and Neck Squamous Cell Carcinoma (MESH:D000077195)
- **Chemicals:** DMEM (-), ComBat (MESH:C041642), hematoxylin (MESH:D006416), penicillin (MESH:D010406), Tween-20 (MESH:D011136), PVDF (MESH:C024865), BCA (MESH:C047117), CO2 (MESH:D002245), streptomycin (MESH:D013307), saline (MESH:D012965), SDS (MESH:D012967), water (MESH:D014867), TRIzol (MESH:C411644)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Cell lines:** CAL27 — Homo sapiens (Human), Tongue adenosquamous carcinoma, Cancer cell line (CVCL_1107), HOK — Homo sapiens (Human), Transformed cell line (CVCL_B404)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926659/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926659/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926659/full.md

---
Source: https://tomesphere.com/paper/PMC12926659